Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nhoa | Paris | Energy | Renewable Energy | €347.01M | -7x | -0.09 | €1.26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €259.63M | 43x | -1.74 | €25.85 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
Aramis | Paris | Consumer Cyclicals | Diversified Retail | €522.55M | -10.5x | -0.41 | €6.34 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.6% Downside | Upgrade to Pro+ | |
Chemin Fer Tramways Var Gard | Paris | Financials | Investment Banking & Investment Services | €659.93M | 292.7x | 15.37 | €10,500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Explosifs Prod Chimiques | Paris | Basic Materials | Chemicals | €371.25M | 17.3x | 1.02 | €176.50 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.9% Upside | Upgrade to Pro+ | |
Marie Brizard Wine & Spirits | Paris | Consumer Non-Cyclicals | Beverages | €444.18M | 43.7x | 0.08 | €3.97 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.3% Downside | Upgrade to Pro+ |